Hepatic hemangioma pathophysiology

Hepatic hemangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatic Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatic hemangioma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatic hemangioma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatic hemangioma pathophysiology
CDC on Hepatic hemangioma pathophysiology
Hepatic hemangioma pathophysiology in the news
Blogs on Hepatic hemangioma pathophysiology
Directions to Hospitals Treating Hepatic hemangioma
Risk calculators and risk factors for Hepatic hemangioma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Development of hepatic hemangioma is the result of genetic mutations, overexpression of angiogenic fators and downregulation of inhibitors of angiogenesis. Hepatic hemangioma may be associated with Kasabach-Merritt syndrome, hereditary hemorrhagic telangiectasia, hepatic arterio-portal shunts, extra hepatic hemangiomata, hemolytic anemia, focal nodular hyperplasia. On gross pathology, variable in size, well circumscribed, and classically subcapsular are findings of hepatic hemangioma. On microscopic histopathological analysis channels lined by benign endothelium containing RBCs, surrounding (non-endothelial) cells without significant atypia are findings of hepatic hemangioma.

Pathogenesis

The pathogenesis of hepatic hemangiomas has not been elucidated, but there are two competing theories.

First theory

• The first theory supports the notion that there is overexpression of angiogenic factors such as:

• Vascular endothelial growth factor
• Basic fibroblast growth factor
• Metalloproteinases

• And there is downregulation of some inhibitors of angiogenesis such as:

• Tissue inhibitor of metalloproteinase-I

Second theory

• The second theory is that the presence of liver hemangiomas involves a genetic background of mutations.
• Zhang et al. presumed that metalloproteinases accumulate in the endoplasmic reticulum of the tumor cells causing:

• Self-digestion
• Vacuole formation

• Additionally, Hu et al. showed the cavernous hemangioma cell to downregulate Derlin-1.

• Derlin-1 is a protein that when overexpressed induces the dilated endoplasmic reticulum to return to its normal size.

Associated Conditions

Hepatic hemangioma may be associated with:

• Kasabach-Merritt syndrome
• Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
• Hepatic arterio-portal shunts
• Extra hepatic hemangiomata
• Hemolytic anemia
• Consumptive coagulopathy
• Focal nodular hyperplasia

Gross Pathology

On gross pathology, variable in size, well circumscribed, and classically subcapsular are findings of hepatic hemangioma.

Microscopic Pathology

On microscopic histopathological analysis channels lined by benign endothelium containing RBCs, surrounding (non-endothelial) cells without significant atypia are findings of hepatic hemangioma.

Gallery

• 

  Intermediate magnification micrograph of a cavernous hemangioma of the liver, also hepatic cavernous hemangioma, liver hemangioma,cavernous liver hemangioma. H&E stain. No liver tissue is observed.

• 

  High magnification micrograph of a cavernous hemangioma of the liver, also hepatic cavernous hemangioma, liver hemangioma,cavernous liver hemangioma. H&E stain. No liver tissue is observed.